GPT-5.5 Bio Bug Bounty

OpenAI has launched a comprehensive bug bounty program targeting GPT-5.5, focusing specifically on biosafety vulnerabilities and potential jailbreaks. The initiative represents a significant step in proactive AI safety research, inviting security researchers and AI experts to identify critical weaknesses in the model's safeguards against misuse of biological information. This red-teaming challenge underscores the growing importance of responsible AI development as language models become increasingly capable.

The GPT-5.5 Bio Bug Bounty offers rewards ranging up to $25,000 for researchers who successfully identify universal jailbreaks or safety bypasses related to biological content. Participants are tasked with discovering methods that could circumvent the model's safety guidelines, potentially exposing risks in how GPT-5.5 handles sensitive biotechnology and biological research information. The program operates as a structured red-teaming exercise, allowing OpenAI to identify and address vulnerabilities before they can be exploited maliciously.

• Enhanced biosafety protocols: The bounty directly strengthens OpenAI's ability to defend against misuse of AI in biological research and bioweapon development
• Industry standard-setting: This initiative may influence how other AI companies approach safety testing and vulnerability disclosure
• Researcher engagement: The financial incentives encourage the global security community to participate in responsible disclosure practices
• Risk identification: Early detection of jailbreaks enables faster remediation before public deployment
• Regulatory alignment: The program demonstrates commitment to safety standards that may inform future AI regulation
• Competitive advantage: Robust safety testing positions GPT-5.5 as a more trustworthy enterprise solution

The GPT-5.5 Bio Bug Bounty reflects the AI industry's evolving understanding that advanced language models require specialized safety oversight. As AI systems become more sophisticated and accessible, the potential for dual-use concerns—where beneficial technology could be repurposed for harm—increases substantially. By proactively inviting expert scrutiny and offering significant financial rewards, OpenAI acknowledges that comprehensive AI safety depends on collaborative, transparent vulnerability disclosure. This approach establishes a precedent for responsible AI development and demonstrates that leading AI companies take biosafety risks seriously, ultimately building greater public trust in AI deployment across sensitive domains.